|
FDA致力于确保胰岛素和其他生物制品的监管平稳过渡
2020.02.20
FDA Works to Ensure Smooth Regulatory Transition of Insulin and Other Biological Products
Today, the U.S. Food and Drug Administration took additional steps to ensure a smooth regulatory transition aimed at increasing patient access to insulin prod...
|
